Biomarkers & Bioinformatics in Clinical Trials and Clinical Studies
Dear CCBIO members, CCBIO associates, and researchers focusing on biomarker detection through use of patient material and advanced bioinformatics tools. We have the pleasure of inviting you to: Biomarkers & Bioinformatics in Clinical Trials and Clinical Studies Symposium, June 18th-19th 2017 at Solstrand Hotel.
Main content
We have brought together speakers with an in-depth knowledge and experience within essential areas of biomarker identification, sharing how they work with clinical samples and bioinformatics in the search for specific biomarkers for a disease or treatment response.
There will also be ample time for interaction between the participants during this meeting. The symposium is open for all, so please feel free to circulate this invitation.
Participants, particularly PhD and MSc students, are encouraged to bring a poster on their work. No abstract required.
Scientific program
SUNDAY 18. June
13.30‐14.15 | Arrival and registration | |
14.15‐14.30 | Welcome | Sonia Gavasso |
14.30‐15.15 | The role of bioinformatics and clinical trials in the discovery of biomarkers | Ola Myklebost |
15.15-15.40 | Break | |
Working with complex data | ||
15.40-16.05 | Genomics: how to select the right approach to identify true biomarkers | Leonardo Meza-Zepeda |
16.05-16.30 | The key role of proteomics in biomarker discovery | Harald Barsnes |
16.30-16.55 | Novel approach for extracting information from experiments with multiple input factors | Ellen Mosleth |
16.55-17.15 | Break | |
17.15-17.30 | Topological data analysis | Morten Brun |
17.30-17.50 | Ultra-deep sequencing of mitochondrial DNA in single cells | Gonzalo Nido |
17.50-18.10 | Integrated analysis of epigenomic and gene expression | Endre Anderssen |
19.30 | Dinner - Enjoy a culinary experience at Solstrand Hotel & Bad with participants and presenters |
MONDAY 19. June
Clinical trials | ||
09.00-09.30 | What are clinical trials? | Nina Jebsen |
09.30-09.50 | Patient's view on clinical trials | Patient |
09.50-10.10 | Break | |
Clinical trials for biomarker detection and evaluation - opportunities, benefits and challenges | ||
10.10-10.30 | A clinician's view | Christian Vedeler |
10.30-10.50 | A molecular biologist's view | Reidun Kopperud |
10.50-11.10 | The biostatistician's view | Nello Blaser |
11.10-11.30 | The ethicist's view | Roger Strand |
11.30-12.30 | Lunch | |
Sample and data management | ||
12.30-12.45 | Biobank Haukeland, the research biobank at Haukeland University Hospital | Ann Cathrine Kroksveen |
12.45-13.00 | Pubgene for management and interpretation of genomic data | Randi Hovland |
13.00-13.15 | CytBASE | Stein-Erik Gullaksen |
13.15-13.45 | Big data | Eirik Thorsnes |
13.45-14.10 | National services offered by Elixir Norway for non-sensitive and sensitive molecular Life Science data: NeLS and TSD | Kjell Petersen |
14.10-14.30 | Break | |
Clinical mass cytometry | ||
14.30-14.50 | A practical example: A cross-sectional study for disease mechanisms in rheumatoid arthritis | Lucius Bader |
14.50-15.10 | Antibody monitoring in multiple sclerosis | Gerd Bringeland |
15.10-15.30 | An analytical approach: Are there any biomarker relevant molecular changes out there? | Jørn Skavland |
15.30-15.45 | Centre for Digital Life Norway - Opportunities for multidisciplinary research and innovation | Rune Kleppe |
15.45-15.55 | Closing remarks | Ellen Mostleth and Sonia Gavasso |
See attachment below for printer friendly program.